E-mail: info@tlph.com.la
Chinese
News
TLPH MET inhibitor Teponi (Tepotinib) approved by LDD
Author:admin
Time:2023-08-14

Teponi (Tepotinib) 


What Teponi is used for


Teponi contains the active substance Tepotinib.

Teponi is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelialtransition (MET)exon 14 skipping alterations

Teponi is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that:

·has spread to other parts of the body (metastatic), and

. whose tumors have an abnormal mesenchymal epithelial transition (MET)gene. Your healthcare provider will perform a test to make sure thatTeponi is right for you.


How Teponi works

Teponi is a kinase inhibitor that targets MET, including valiants with exon 14 skipping alterations. Teponi inhibits hepatocyte growth factor(HGF)-dependent and -independent MET phospho¹ylation and MET-dependent downstream signaling pathways. Teponi also inhibited melatonin2 and imidazoline 1 receptors at clinically achievable concentrations.

If you have any questions on how Teponi works or why it has been prescribed for you, ask your doctor, pharmacist or nurse.


tebo in 800.jpg


Contact Us
Address: Rd.13 South, 31 km Ban Naphasuk, SaithanyDistrict, Vientiane, Lao PDR
E-mail: info@tlph.com.la
WeChat: TLPH01
Website: https: //tlph.com.la
Copyright © 2017 TLPH. All rights reserved. Technical Support:web100
Copyright © 2017 TLPH. All rights reserved.
Technical Support:web100